If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKeras Resources Regulatory News (KRS)

  • This share is currently suspended. It was suspended at a price of 1.40

Share Price Information for Keras Resources (KRS)

Share Price is delayed by 15 minutes
Get Live Data
1.40    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £2.20m
KRS Live PriceLast checked at - London Stock Exchange

Intraday Keras Resources Share Chart

Lodged Prospectus for ASX Listing

8 May 2017 07:00

RNS Number : 3970E
Keras Resources PLC
08 May 2017
 

Keras Resources plc / Index: AIM / Epic: KRS / Sector: Mining

8 May 2017

Keras Resources plc ("Keras" or "the Company")

Lodged Prospectus for ASX Listing

 

Keras Resources plc, the AIM listed mineral resource company, is pleased to confirm that ASX quoted Pharmanet Group Limited ("Pharmanet") lodged a prospectus with the Australian Securities and Investments Commission (the "Prospectus") on 5 May 2017. The Prospectus has been lodged in order to raise A$7.8 million (approximately £4.6 million) (the "ASX Capital Raising") as part of the proposed acquisition by Pharmanet of 100% of the issued share capital of the Company's wholly owned subsidiary Keras (Gold) Australia Pty Ltd ("Keras Australia") as previously announced on 21 March 2017 (the "Transaction"). Pharmanet is anticipated to relist as Calidus Resources Limited ("Calidus") in June 2017.

 

The ASX Capital Raising follows the recent oversubscribed raising by Pharmanet of A$0.6 million from sophisticated investors, as announced by Keras on 18 April 2017. Funds raised will be used to undertake a major drilling and exploration programme at the Warrawoona Gold Project and to undertake initial Scoping Studies, as well as repay the Acquisition Finance Facility.

 

Keras Managing Director Dave Reeves said, "We are delighted that the proposed acquisition by Pharmanet of our Australian gold assets continues to progress on schedule. The lodging of this Prospectus marks an important step in listing Keras Australia on the ASX and having received significant interest in the recent A$0.6 million fundraise, we are confident that Pharmanet will receive strong support as it looks to raise A$7.8 million. As a standalone ASX listed gold company, with a strong balance sheet, experienced board and management team, which includes Keras board representation, and defined development strategy, we believe Pharmanet, or soon to be Calidus, is primed to unlock value for all shareholders. We look forward to continuing to deliver on the development milestones, as detailed in our recent Notice of General Meeting, as we target the listing of Calidus in June 2017."

 

A copy of the prospectus is available at www.calidus.com.au.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

**ENDS**

 

For further information please visit www.kerasplc.com, follow us on Twitter @kerasplc or contact the following:

 

 

Dave Reeves

 

Keras Resources plc

 

dave@kerasplc.com

 

Nominated Adviser

Gerry Beaney/David Hignell

Northland Capital Partners Limited

+44 (0) 20 3861 6625

 

Broker

 

Elliot Hance/Jonathon Belliss

Beaufort Securities Limited

+44 (0) 20 7382 8415

Damon Heath/Erik Woolgar

Shard Capital Ltd

+44 (0) 20 7186 9952

Tom Curran/Ben Tadd

SVS Securities

+44 (0) 20 3700 0093

 

Financial PR

Susie Geliher/Charlotte Page

St Brides Partners Limited

+44 (0) 20 7236 1177

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCOKODNCBKDFPK
Date   Source Headline
1st Jul 20267:30 amRNSSuspension - Keras Resources Plc
30th Jun 20261:14 pmRNSAnnual Results Update & Suspension
29th Sep 20257:00 amRNSInterim results
26th Sep 20257:00 amRNSCorporate Update
14th Aug 20254:40 pmRNSIssue of Shares to Russell Lamming
14th Aug 20252:28 pmRNSResult of Open Offer and General Meeting
14th Aug 20252:07 pmRNSResult of Annual General Meeting
8th Aug 20257:00 amRNSCorporate Update
21st Jul 20257:05 amRNSNotice of Annual General Meeting
21st Jul 20257:00 amRNSLaunch of Open Offer and Rule 9 Waiver
30th Jun 20257:00 amRNSFinal Results
26th Jun 20253:00 pmRNSIssue of Convertible Loan Notes
6th Jun 20257:00 amRNSTogo Update
7th Apr 20253:43 pmRNSIssue of New Shares
4th Apr 20257:00 amRNSCorporate Update
26th Mar 20257:00 amRNSCorporate Update
17th Jan 20257:00 amRNSManagement Change
4th Dec 20249:40 amRNSTotal Voting Rights
31st Oct 20244:04 pmRNSHolding(s) in Company
31st Oct 20244:03 pmRNSHolding(s) in Company
29th Oct 20247:00 amRNSSubscription to Raise £372,500
26th Sep 20247:00 amRNSInterim Results
23rd Sep 20247:00 amRNSOperations Update – Diamond Creek Project
1st Aug 20247:00 amRNSCommencement of commercial production at Delta
26th Jul 20242:33 pmRNSResult of AGM
28th Jun 20247:00 amRNSNotice of AGM
28th Jun 20247:00 amRNSHot Commissioning of Integrated Processing Plant
27th Jun 20247:00 amRNSFinal Results
3rd Jun 20247:00 amRNSCommissioning of Integrated Delta Processing Plant
28th May 20247:00 amRNSIssue of Convertible Loan Notes and Loans
9th May 20247:00 amRNSNayéga Update
29th Apr 20247:00 amRNSQ1 2024 Operations and Sales Update
29th Feb 20247:00 amRNSTotal Voting Rights
23rd Feb 20247:00 amRNSOperations Update and award of Options
2nd Feb 20247:00 amRNSIssue of Fee Shares
22nd Jan 20247:00 amRNSGranulator Plant JV and Acquisition of Property
17th Jan 20247:00 amRNSChange of Auditor
22nd Nov 20237:00 amRNSHolding(s) in Company
3rd Oct 202311:52 amRNSHolding(s) in Company
29th Sep 20237:00 amRNSInterim Results
4th Sep 20231:58 pmRNSHolding(s) in Company
16th Aug 20232:04 pmRNSHolding(s) in Company
1st Aug 202310:41 amRNSResult of AGM
6th Jul 20234:20 pmRNSRestoration - Keras Resources plc
6th Jul 20234:20 pmRNSRestoration of Trading on AIM
6th Jul 20237:00 amRNSFinal Results for the Year Ended 31 December 2022
5th Jul 20235:45 pmRNSHolding(s) in Company
4th Jul 20234:55 pmRNSReceipt of funds from the Republic of Togo
3rd Jul 20237:30 amRNSSuspension - Keras Resources plc
3rd Jul 20237:00 amRNSAnnual Results Update & Suspension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.